Dolutegravir in the long term in children and adolescents: frequent virological failure but rare acquired genotypic resistance-Reference-Cited by-同舟云学术

Dolutegravir in the long term in children and adolescents: frequent virological failure but rare acquired genotypic resistance

Published:2021-08-08 Issue:10 Volume:22 Page:958-964
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Frange Pierre¹²³^ORCID,Blanche Stephane³⁴,Veber Florence³,Avettand‐Fenoel Veronique¹⁴⁵

Affiliation:

1. Laboratoire de Microbiologie clinique Hôpital Necker – Enfants Malades Groupe hospitalier Assistance Publique – Hôpitaux de Paris Centre Université de Paris (APHP.CUP) Paris France

2. EHU 7328 PACT Institut Imagine Université de Paris Paris France

3. Unité d’Immunologie, Hématologie et Rhumatologie Pédiatriques AP‐HP Hôpital Universitaire Necker – Enfants Malades Paris France

4. Université de Paris Paris France

5. U1016 CNRS UMR8104 Institut Cochin INSERM Paris France

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13154

Reference18 articles.

1. Risk of triple-class virological failure in children with HIV: a retrospective cohort study

2. SengR BignaJJ FayeA et al.Poorer control of viral load in patients infected perinatally versus during adulthood. Abstract 0807. 26th Conference on Retroviruses and Opportunistic Infections Seattle Washington USA 2019.

3. HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review

4. World Health Organization.HIV treatment. Update of recommendations on first‐ and second‐line antiretroviral regimens. July 2019. Available at:https://www.who.int/hiv/pub/arv/arv‐update‐2019‐policy/en/

5. Efficacy and tolerance of dolutegravir‐based combined ART in perinatally HIV‐1‐infected adolescents: a French multicentre retrospective study;Briand C;J Antimicrob Chemother.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Optimization of Oligonucleotide Ligation Assay (OLA) Probes for Detection of HIV-1 Resistance to Dolutegravir;Viruses;2024-07-19

2. Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014;Journal of the Pediatric Infectious Diseases Society;2023-10-10

3. Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023);HIV Medicine;2023-10-08

4. Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review;Viruses;2023-09-15

5. Virologic Outcomes and ARV Switch Profiles 2 Years After National Rollout of Dolutegravir to Children Less Than 15 Years in Southern Mozambique;Pediatric Infectious Disease Journal;2023-07-06